JNK modulates positively the PAI-1 expression in the neurodegenerative amyloid pathology observed in Alzheimer’s disease (Gerenu et al., 2017), whereas JNK inhibition significantly attenuates the induction of PAI-1 (Eurlings et al., 2017). The gene discussed is MAPK8; the disease is early-onset autosomal dominant Alzheimer disease.